[Boston, 23 August 2025] – The global transcutaneous oximetry systems (TcPO₂) market is projected to expand from USD 0.31 billion in 2024 to USD 0.65 billion by 2031, reflecting an impressive CAGR of 11.1%, according to Clearview Market Insights (CVMI).

The surge is fueled by the increasing prevalence of chronic wounds, diabetic complications, and peripheral artery disease (PAD), which are intensifying demand for non-invasive oxygenation diagnostics.

Request Sample: https://clearviewmarketinsights.com/report-details/global-transcutaneous-oximetry-system-market/

“Transcutaneous oximetry is now integral to vascular and wound healing workflows, with clinicians depending on it to guide interventions and assess tissue viability,” noted Dr. Kavita Rao, Senior Medical Diagnostics Analyst at CVMI.

Industry leaders such as Perimed AB, Radiometer, and Moor Instruments are shaping the future of this market with next-generation systems that integrate artificial intelligence, mobile connectivity, and dual-probe functionality. Notably, Perimed’s AI-powered healing prediction module and Radiometer’s expansion in Latin America highlight innovation and global outreach, while Moor Instruments’ launch of a simplified home-use model underscores the shift toward decentralized care.

Clinically, TcPO₂ has become indispensable for limb salvage assessments and diabetic foot ulcer management, particularly in high-risk populations. Its growing use in ambulatory surgical centers and homecare settings reflects the demand for portable and user-friendly solutions.

On the policy front, global healthcare systems are advancing reimbursement coverage. The CMS in the United States and European health programs now support TcPO₂-based diagnostics for wound care and PAD evaluation. Meanwhile, Asia-Pacific is witnessing accelerated adoption in India and China, and Latin America and Africa are seeing growth through mobile diagnostic units and NGO initiatives.

Looking ahead, the market outlook is highly positive as manufacturers align their solutions with outpatient care, AI-driven predictive tools, and digital health integration. Positioned at the intersection of precision medicine and home-based care, TcPO₂ is emerging as a vital tool for the future of vascular diagnostics and chronic disease management.

For more insights, visit https://clearviewmarketinsights.com/

About Clearview Market Insights:

Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.

Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights